Predicting 30-day heart problems after gastrointestinal surgery using AI versus standard risk scores
Official title: Value of Some Risk Scores in Predicting Cardiovascular Events After Gastrointestinal Surgery
Run by Bach Mai Hospital · NCT07539532 · Data updated 2026-11-12
This project will test whether an AI-based multimodal model can better predict major heart problems within 30 days after gastrointestinal surgery for adults at Bach Mai Hospital than commonly used risk scores.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Bach Mai Hospital Academic / other |
| Locations | 1 site (Hà Nội) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | June 30, 2026 |
| Study ends | July 31, 2026 |
| Registry record updated | April 20, 2026 |
| Trial ID | NCT07539532 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult patients (age ≥18) undergoing gastrointestinal surgery at Bach Mai Hospital between January 2025 and December 2026 with sufficient preoperative, intraoperative, and postoperative data are the intended participants.
✕Probably not a fit
Patients without the required clinical data, those who die within 24 hours from a clearly non-cardiovascular cause, pediatric patients, or those undergoing non-gastrointestinal procedures are unlikely to benefit from this model.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a mixed retrospective–prospective observational effort at Bach Mai Hospital to develop an AI-based multimodal prediction model for major cardiovascular events occurring within 30 days after gastrointestinal surgery. The model will draw on preoperative, intraoperative, and postoperative clinical, laboratory, physiologic, and procedural data from adult patients treated in 2025–2026. Investigators will compare the AI model's predictive performance with traditional scores (RCRI, ACS NSQIP MICA, and ACS NSQIP SRC) using measures such as discrimination, calibration, and clinical usefulness. The primary outcome is major cardiovascular events (cardiovascular death, nonfatal MI, cardiac arrest with return of spontaneous circulation, new stroke, and related events) within 30 days after surgery.
Why it matters
Potential benefit: If successful, the AI model could more accurately identify patients at high risk of early postoperative cardiovascular events, enabling closer monitoring and targeted preventive care.
How similar studies have gone: Some prior machine-learning models have improved prediction of surgical and cardiac outcomes, but multimodal AI models with robust external or prospective validation remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older. * Undergoing gastrointestinal surgery at Bach Mai Hospital between January 2025 and December 2026. * Available preoperative, intraoperative, and postoperative data sufficient for analysis. Exclusion Criteria: * Death within 24 hours after surgery due to a clearly non-cardiovascular cause. * Incomplete data required for analysis.
Where it's running
-
Bach Mai hospital
Hà Nội, Vietnam Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting depression in patients after heart surgery
This study is trying to see if a new tool can help predict which patients might develop depression after heart surgery, so they can get help sooner.
-
Biological mesh reinforcement for digestive tract reconstruction
This study tests whether inserting a biological mesh during alimentary tract reconstruction can reduce bleeding and complications after digestive surgery.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.